Skip to content

Innospec IOSP Other Commercial Liabilities

Other Commercial Liabilities at other companies

NewMarket logo
NewMarketNEU
Ashland logo
AshlandASH
CSW Industrials, Inc. logo
CSW Industrials, Inc.CSW
Chemours logo
ChemoursCC
Ingevity logo
IngevityNGVT
Avient logo
AvientAVNT

Other financials

Income statement

See full
Revenue$453.2M+2.8%
Gross profit$123.5M-1.3%
Operating income$36.5M-14.1%
Net income$30.4M-7.3%
EPS (diluted)$1.22-6.9%

Balance sheet

See full
Cash & equivalents$289.1M-3.6%
Total debt$50.6M+14.0%
Total equity$1.3B+6.7%
Total assets$1.8B+2.5%

Cash flow

See full
Operating cash flow$17.6M-37.8%
CapEx$8.9M+6.0%
Free cash flow$8.7M-56.3%

Valuation

See full
Market cap$2.05B-23.6%

Profitability

See full
Gross margin27.4%-1.3pp
Operating margin6.9%-2.6pp
Net margin6.4%
FCF margin4.5%-1.1pp

Returns & leverage

See full
Return on equity8.8%
Debt / equity0.0×
Current ratio+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Innospec’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innospec's other commercial liabilities?
Innospec (IOSP) reported other commercial liabilities of $169.3M in Q1 2026.
How has Innospec's other commercial liabilities changed year-over-year?
Innospec's other commercial liabilities increased by 14.8% year-over-year, from $147.5M to $169.3M.
What is the long-term trend for Innospec's other commercial liabilities?
Over 5 years (2020 to 2025), Innospec's other commercial liabilities has grown at a 3.2% compound annual growth rate (CAGR), from $129.8M to $152.3M.